SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-023634
Filing Date
2013-04-24
Accepted
2013-04-24 16:44:19
Documents
4
Period of Report
2013-06-05
Effectiveness Date
2013-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT v342057_def14a.htm DEF 14A 305598
2 GRAPHIC tlogo.jpg GRAPHIC 11810
3 GRAPHIC card1.jpg GRAPHIC 107479
4 GRAPHIC card2.jpg GRAPHIC 83648
  Complete submission text file 0001144204-13-023634.txt   586927
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 13779698
SIC: 2834 Pharmaceutical Preparations